Japan-based Softbank to Set Up $120 Million Life Science Fund | GenomeWeb

NEW YORK, Jan 26 – Tokyo-based Softbank plans to set up a $120 million fund to finance life science companies, a spokeswoman said Friday.

The fund will target companies in the US, Europe, and Asia, beginning in April or May.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.